AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOBR Safe, Inc. Director's Dealing 2019

Sep 13, 2019

35413_dirs_2019-09-13_36f91a30-dc20-4f56-9a5b-70f3d37350f5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransBiotec, Inc. (IMLE)
CIK: 0001425627
Period of Report: 2019-08-28

Reporting Person: Bennington Charles Warren (Director, CEO, President and Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-28	Common Stock	P	14000000	$0.0425	Acquired	15004422	Direct

Footnotes

F1: The Reporting Person acquired 14,000,000 shares of the Issuer's common stock in exchange for forgiving $595,000 owed to him as accrued salary under the terms of a Common Stock Purchase Agreement.